These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 16353278

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A, Najafnia L, Daraee B, Dadrass OG, Hedayati M.
    Bioorg Med Chem Lett; 2007 Oct 15; 17(20):5634-7. PubMed ID: 17822894
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.
    Cheng H, Lundy DeMello KM, Li J, Sakya SM, Ando K, Kawamura K, Kato T, Rafka RJ, Jaynes BH, Ziegler CB, Stevens R, Lund LA, Mann DW, Kilroy C, Haven ML, Nimz EL, Dutra JK, Li C, Minich ML, Kolosko NL, Petras C, Silvia AM, Seibel SB.
    Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2076-80. PubMed ID: 16464588
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and screening of cyclooxygenase inhibitory activity of some 1,3-dioxoisoindoline derivatives.
    Cizmeciolu M, Pabuguoglu V, Ballar P, Pabuççuoğlu A, Soyer Z.
    Arzneimittelforschung; 2011 Apr 15; 61(3):186-90. PubMed ID: 21528644
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors.
    Khanapure SP, Garvey DS, Young DV, Ezawa M, Earl RA, Gaston RD, Fang X, Murty M, Martino A, Shumway M, Trocha M, Marek P, Tam SW, Janero DR, Letts LG.
    J Med Chem; 2003 Dec 04; 46(25):5484-504. PubMed ID: 14640557
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
    Ghodsi R, Zarghi A, Daraei B, Hedayati M.
    Bioorg Med Chem; 2010 Feb 04; 18(3):1029-33. PubMed ID: 20061161
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design of acyclic triaryl olefins: a new class of potent and selective cyclooxygenase-2 (COX-2) inhibitors.
    Uddin MJ, Rao PN, Knaus EE.
    Bioorg Med Chem Lett; 2004 Apr 19; 14(8):1953-6. PubMed ID: 15050635
    [Abstract] [Full Text] [Related]

  • 12. Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib.
    Giraudel JM, Toutain PL, King JN, Lees P.
    J Vet Pharmacol Ther; 2009 Feb 19; 32(1):31-40. PubMed ID: 19161453
    [Abstract] [Full Text] [Related]

  • 13. Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme.
    Uddin MJ, Rao PN, McDonald R, Knaus EE.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):439-42. PubMed ID: 15603969
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.
    Chen QH, Rao PN, Knaus EE.
    Bioorg Med Chem; 2005 Dec 01; 13(23):6425-34. PubMed ID: 16099663
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of methanesulfonamide analogues of rofecoxib: Replacement of methanesulfonyl by methanesulfonamido decreases cyclooxygenase-2 selectivity.
    Zarghi A, Praveen Rao PN, Knaus EE.
    Bioorg Med Chem; 2007 Jan 15; 15(2):1056-61. PubMed ID: 17067801
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
    Zarghi A, Ghodsi R.
    Bioorg Med Chem; 2010 Aug 15; 18(16):5855-60. PubMed ID: 20650641
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
    Zarghi A, Ghodsi R, Azizi E, Daraie B, Hedayati M, Dadrass OG.
    Bioorg Med Chem; 2009 Jul 15; 17(14):5312-7. PubMed ID: 19560931
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation.
    Pal M, Madan M, Padakanti S, Pattabiraman VR, Kalleda S, Vanguri A, Mullangi R, Mamidi NV, Casturi SR, Malde A, Gopalakrishnan B, Yeleswarapu KR.
    J Med Chem; 2003 Sep 11; 46(19):3975-84. PubMed ID: 12954051
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
    Ranatunge RR, Augustyniak M, Bandarage UK, Earl RA, Ellis JL, Garvey DS, Janero DR, Letts LG, Martino AM, Murty MG, Richardson SK, Schroeder JD, Shumway MJ, Tam SW, Trocha AM, Young DV.
    J Med Chem; 2004 Apr 22; 47(9):2180-93. PubMed ID: 15084117
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of 2,3-diarylpyrazines and quinoxalines as selective COX-2 inhibitors.
    Singh SK, Saibaba V, Ravikumar V, Rudrawar SV, Daga P, Rao CS, Akhila V, Hegde P, Rao YK.
    Bioorg Med Chem; 2004 Apr 15; 12(8):1881-93. PubMed ID: 15051057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.